Incerti Carlo 4
4 · Dyne Therapeutics, Inc. · Filed Nov 18, 2024
Insider Transaction Report
Form 4
Incerti Carlo
Director
Transactions
- Sale
Common Stock
2024-11-18$28.73/sh−16,500$474,045→ 0 total - Exercise/Conversion
Stock option (right to buy)
2024-11-18−16,500→ 22,693 totalExercise: $8.69Exp: 2032-03-01→ Common Stock (16,500 underlying) - Exercise/Conversion
Common Stock
2024-11-18$8.69/sh+16,500$143,385→ 16,500 total
Footnotes (2)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $28.47 to $29.13, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote of this Form 4.
- [F2]The option was granted on March 2, 2022. The shares underlying the option are scheduled to vest over three years in equal monthly installments through March 2, 2025.